Monitoring Ovarian Cancer: CA125 Trial Stirs Controversy

被引：8
|
作者：
Chitale, Radha
机构：
来源：
JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2009年 / 101卷 / 18期
关键词：
D O I：
10.1093/jnci/djp316
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1233 / 1233
页数：1
相关论文
共 50 条
  • [11] Personalizing CA125 Levels for Ovarian Cancer Screening
    Dorigo, Oliver
    Berek, Jonathan S.
    CANCER PREVENTION RESEARCH, 2011, 4 (09) : 1356 - 1359
  • [12] CA125 GLYCOFORM ASSAY IMPROVES THE PERFORMANCE OF CONVENTIONAL CA125 IN THE DIAGNOSTICS OF EPITHELIAL OVARIAN CANCER
    Salminen, L.
    Gidwani, K.
    Rolfsen, A. L.
    Nadeem, N.
    Bolstad, N.
    Dorum, A.
    Grenman, S.
    Hietanen, S.
    Perheentupa, A.
    Poutanen, M.
    Carpen, O.
    Lamminmaki, U.
    Pettersson, K.
    Hynninen, J.
    Huhtinen, K.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 825 - 825
  • [13] THE COST-EFFECTIVENESS OF SERUM CA125 MONITORING IN EPITHELIAL OVARIAN-CANCER
    CRUICKSHANK, DJ
    CAIRNS, J
    BRITISH JOURNAL OF CANCER, 1990, 61 (01) : 178 - 178
  • [14] Ovarian hemangioma with elevated CA125 and ascites mimicking ovarian cancer
    Erdemoglu, E
    Kamaci, M
    Özen, S
    Sahin, HG
    Kolusari, A
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2006, 27 (02) : 195 - 196
  • [15] Potential value of CA125 kinetic monitoring in the initial management of advanced epithelial ovarian cancer
    Vignot, Stephane
    Brochet, Christine
    Debord, Camille
    Lauratet, Betty
    Bernard, Maguy
    ANNALES DE BIOLOGIE CLINIQUE, 2011, 69 (05) : 597 - 604
  • [16] IMMUNOASSAY OF CA125 IN OVARIAN-CANCER - A COMPARISON OF 3 ASSAYS FOR USE IN DIAGNOSIS AND MONITORING
    FISKEN, J
    LEONARD, RCF
    ROULSTON, JE
    DISEASE MARKERS, 1989, 7 (01) : 61 - 67
  • [17] APPROPRIATE USE OF CA125 IN MONITORING OF OVARIAN CANCER- ADVANTAGE OR DISADVANTAGE FOR AN INDIVIDUAL PATIENT
    Zwirner, M.
    Korte, K.
    ANTICANCER RESEARCH, 2014, 34 (11) : 6856 - 6856
  • [18] Longitudinal monitoring of CA125 levels provides additional information about survival in ovarian cancer
    Gupta, Digant
    Lammersfeld, Carolyn A.
    Vashi, Pankaj G.
    Braun, Donald P.
    JOURNAL OF OVARIAN RESEARCH, 2010, 3
  • [19] THE VALUE OF SERUM CA125 FOR MONITORING THE RECURRENCE OF EPITHELIAL OVARIAN CARCINOMA
    Guo, N.
    Zhilan, P.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 56 - 56
  • [20] Correlates of the preoperative level of CA125 at presentation of ovarian cancer
    Cramer, Daniel W.
    Vitonis, Allison F.
    Welch, William R.
    Terry, Kathryn L.
    Goodman, Annekathryn
    Rueda, Bo R.
    Berkowitz, Ross S.
    GYNECOLOGIC ONCOLOGY, 2010, 119 (03) : 462 - 468
12345